Company news

United Therapeutics Corporation news in 2024

United Therapeutics Corporation's news releases, calls and decks from 2024, newest first.

View company

United Therapeutics Announces Successful World’s First UKidney Transplant

December 16, 2024

United Therapeutics Corporation to Present at the UBS Global Healthcare Conference

November 4, 2024

United Therapeutics Corporation Reports Third Quarter 2024 Financial Results

October 29, 2024

United Therapeutics Corporation to Report Third Quarter 2024 Financial Results Before the Market Opens on Wednesday, October 30, 2024

October 22, 2024

United Therapeutics Corporation Announces the 500th Lung Transplant Utilizing its Centralized Ex Vivo Lung Perfusion Service

October 22, 2024

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the CHEST 2024 Annual Meeting

September 23, 2024

United Therapeutics Publishes its 2024 Corporate Responsibility and Public Benefit Report Highlighting its Progress Toward a Future Where No Patient Gets Left Behind—Ever

September 9, 2024

United Therapeutics Corporation Reports Second Quarter 2024 Financial Results

July 30, 2024

United Therapeutics Corporation to Report Second Quarter 2024 Financial Results Before the Market Opens on Wednesday, July 31, 2024

July 23, 2024

United Therapeutics Corporation Announces Full Enrollment of the TETON 2 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis

July 9, 2024

United Therapeutics Corporation Announces Election of Jan Malcolm to its Board of Directors

June 26, 2024

United Therapeutics Corporation to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

June 4, 2024

United Therapeutics Corporation Reports First Quarter 2024 Financial Results

April 30, 2024

United Therapeutics Corporation to Report First Quarter 2024 Financial Results Before the Market Opens on Wednesday, May 1, 2024

April 23, 2024

CORRECTING and REPLACING PHOTO United Therapeutics Announces World’s First Successful Xenothymokidney Transplant

April 23, 2024

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference

April 15, 2024

United Therapeutics Announces the First Comprehensive Review Publication on Xenotransplantation

March 25, 2024

United Therapeutics Corporation to Present at the Leerink Partners Global Biopharma Conference 2024

March 4, 2024

United Therapeutics Corporation to Present at the TD Cowen 44th Annual Health Care Conference

February 26, 2024

United Therapeutics Corporation Reports Fourth Quarter and Full Year 2023 Financial Results

February 20, 2024

United Therapeutics Commences Litigation to Ensure Fairness in the Drug Review Process

February 20, 2024

United Therapeutics Corporation to Report Fourth Quarter and Full Year 2023 Financial Results Before the Market Opens on Wednesday, February 21, 2024

February 13, 2024

Calls in 2024

Decks in 2024